1. To determine the cardiovascular toxicities associated with traditional and novel cancer therapies.
2. To discuss common risk factors that predispose to cardiovascular disease and cancer.
3. To discuss how cardio-oncology can serve as an innovation platform within a medical center.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation